Cargando…

Epigenetic Mechanisms in Hepatic Stellate Cell Activation During Liver Fibrosis and Carcinogenesis

Liver fibrosis is an essential component of chronic liver disease (CLD) and hepatocarcinogenesis. The fibrotic stroma is a consequence of sustained liver damage combined with exacerbated extracellular matrix (ECM) accumulation. In this context, activation of hepatic stellate cells (HSCs) plays a key...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barcena-Varela, Marina, Colyn, Leticia, Fernandez-Barrena, Maite G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566358/ https://www.ncbi.nlm.nih.gov/pubmed/31117267 http://dx.doi.org/10.3390/ijms20102507

Ejemplares similares

Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
por: Claveria-Cabello, Alex, et al.
Publicado: (2020)

Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg
por: Fernández-Barrena, Maite G., et al.
Publicado: (2020)

Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis
por: Garbuzenko, Dmitry Victorovich
Publicado: (2022)

β-PDGF Receptor Expressed by Hepatic Stellate Cells Regulates Fibrosis in Murine Liver Injury, but Not Carcinogenesis
por: Kocabayoglu, Peri, et al.
Publicado: (2015)

Hepatic stellate cells: central modulators of hepatic carcinogenesis
por: Thompson, Alexandra I, et al.
Publicado: (2015)

Epigenetic regulation during hepatic stellate cell activation
por: Götze, Silke, et al.
Publicado: (2014)

Epigenetic Changes during Hepatic Stellate Cell Activation
por: Götze, Silke, et al.
Publicado: (2015)

Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis
por: Nokkeaw, Archittapon, et al.
Publicado: (2023)

Hepatic stellate cells and parasite-induced liver fibrosis
por: Anthony, Barrie, et al.
Publicado: (2010)

Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
por: Khomich, Olga, et al.
Publicado: (2019)

Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis
por: Zhao, Yuan-Quan, et al.
Publicado: (2023)

Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease
por: Chen, Chaobo, et al.
Publicado: (2021)

Epigenetic Regulation of Hepatic Stellate Cell Activation and Macrophage in Chronic Liver Inflammation
por: Shi, Chun-xia, et al.
Publicado: (2021)

Activation of Hepatic Stellate Cells During Liver Carcinogenesis Requires Fibrinogen/Integrin αvβ5 in Zebrafish
por: Yan, Chuan, et al.
Publicado: (2018)

Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis
por: Kitano, Mio, et al.
Publicado: (2016)

Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis
por: Cho, Eun-Hee
Publicado: (2018)

Hepatic stellate cell hypertrophy is associated with metabolic liver fibrosis
por: Hoffmann, Céline, et al.
Publicado: (2020)

The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis
por: Lambrecht, Joeri, et al.
Publicado: (2015)

Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis
por: Charan, Harsh Vardhan, et al.
Publicado: (2022)

Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging
por: Li, Dan, et al.
Publicado: (2015)

Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis
por: Zhao, Xue-Ke, et al.
Publicado: (2017)

Role of Hepatocyte Senescence in the Activation of Hepatic Stellate Cells and Liver Fibrosis Progression
por: Wijayasiri, Pramudi, et al.
Publicado: (2022)

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression
por: Ye, Bingyu, et al.
Publicado: (2023)

Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis
por: Ogawa, Hiroyuki, et al.
Publicado: (2021)

Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
por: Chen, Zhijin, et al.
Publicado: (2019)

Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis
por: Pu, Shiyun, et al.
Publicado: (2021)

Does CB-1 in hepatic stellate cells contribute to liver fibrosis?
por: Lotersztajn, Sophie, et al.
Publicado: (2022)

Crosstalk between NK cells and hepatic stellate cells in liver fibrosis
por: Zhang, Yang, et al.
Publicado: (2022)

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis
por: Yin, Xiaochun, et al.
Publicado: (2022)

Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease
por: Arechederra, María, et al.
Publicado: (2021)

Molecular mechanism of stellate cell activation and therapeutic strategy for liver fibrosis
por: Kawada, Norifumi
Publicado: (2004)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
por: Schon, Hans-Theo, et al.
Publicado: (2016)

Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis
por: Duval, Florent, et al.
Publicado: (2014)

Liver Fibrosis and Protection Mechanisms Action of Medicinal Plants Targeting Apoptosis of Hepatocytes and Hepatic Stellate Cells
por: Duval, Florent, et al.
Publicado: (2014)

RASAL1 is a potent regulator of hepatic stellate cell activity and liver fibrosis
por: Takata, Akemi, et al.
Publicado: (2017)

Multiple functions of MLKL in liver fibrosis, from necroptosis to hepatic stellate cell activation
por: Pistorio, Valeria, et al.
Publicado: (2022)

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability
por: Yang, Xiao-Mei, et al.
Publicado: (2022)

Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis
por: Knorr, Jana, et al.
Publicado: (2023)

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets
por: Zhang, Chong-Yang, et al.
Publicado: (2016)

GATA4 induces liver fibrosis regression by deactivating hepatic stellate cells
por: Arroyo, Noelia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_anrh3ruhqbe3khklk1q75vn81m